PRJEB1986: zebrafish developmental stages transcriptome
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
foxf2a | dr11_v1_chr2_-_716426_716426 | -0.63 | 3.6e-03 | Click! |
foxf1 | dr11_v1_chr18_+_30847237_30847237 | -0.63 | 4.0e-03 | Click! |
foxf2b | dr11_v1_chr20_+_26690036_26690036 | -0.57 | 1.0e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr4_+_15944245 Show fit | 0.75 |
ENSDART00000134594
|
si:dkey-117n7.3 |
|
chr12_+_3912544 Show fit | 0.42 |
ENSDART00000013465
|
T-box 6 |
|
chr1_+_51191049 Show fit | 0.41 |
ENSDART00000132244
ENSDART00000014970 ENSDART00000132141 |
BTB (POZ) domain containing 3a |
|
chr1_-_9134045 Show fit | 0.37 |
ENSDART00000142132
|
partner and localizer of BRCA2 |
|
chr23_-_27152866 Show fit | 0.31 |
ENSDART00000141305
|
si:dkey-157g16.6 |
|
chr6_+_34028532 Show fit | 0.30 |
ENSDART00000155827
|
si:ch73-185c24.2 |
|
chr14_-_9713549 Show fit | 0.28 |
ENSDART00000193356
ENSDART00000166739 |
si:zfos-2326c3.2 |
|
chr9_+_41459759 Show fit | 0.26 |
ENSDART00000132501
ENSDART00000100265 |
nuclear envelope integral membrane protein 2 |
|
chr13_-_18011168 Show fit | 0.26 |
ENSDART00000144813
|
membrane-associated ring finger (C3HC4) 8 |
|
chr8_-_13985032 Show fit | 0.26 |
ENSDART00000140576
|
insulin-like growth factor 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.5 | GO:0009229 | thiamine diphosphate biosynthetic process(GO:0009229) |
0.1 | 0.4 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.1 | 0.4 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.0 | 0.4 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.4 | GO:0034724 | DNA replication-independent nucleosome organization(GO:0034724) |
0.0 | 0.4 | GO:0048264 | determination of ventral identity(GO:0048264) |
0.0 | 0.3 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.0 | 0.3 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.1 | 0.2 | GO:0060843 | lymphatic endothelial cell fate commitment(GO:0060838) venous endothelial cell differentiation(GO:0060843) venous endothelial cell fate commitment(GO:0060845) |
0.1 | 0.2 | GO:0010755 | regulation of plasminogen activation(GO:0010755) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.5 | GO:0035101 | FACT complex(GO:0035101) |
0.0 | 0.3 | GO:0030686 | 90S preribosome(GO:0030686) |
0.0 | 0.3 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.1 | 0.2 | GO:0031213 | RSF complex(GO:0031213) |
0.1 | 0.2 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
0.0 | 0.2 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.0 | 0.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.2 | GO:0030914 | STAGA complex(GO:0030914) |
0.0 | 0.2 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.2 | GO:0048179 | activin receptor complex(GO:0048179) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.5 | GO:0004788 | thiamine diphosphokinase activity(GO:0004788) thiamine binding(GO:0030975) |
0.0 | 0.3 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 0.3 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.3 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.0 | 0.3 | GO:0042287 | MHC protein binding(GO:0042287) |
0.1 | 0.2 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.0 | 0.2 | GO:0035671 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) enone reductase activity(GO:0035671) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.0 | 0.2 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.2 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.0 | 0.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.5 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 0.3 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.3 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.6 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.5 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.3 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 0.3 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.0 | 0.2 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 0.1 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |